BioCentury | Mar 24, 2021
Finance

With cancer foot forward, Step making strides toward clinic with €35M series B

...biotech concluded that the oncology route offered a shorter route to a potential accelerated approval.Now, Step Pharma S.A.S....
...Kurma were prior investors Pontifax and Bpifrance.TARGETSCTPS1 - CTP synthase 1CTPS2 - CTP synthase 2 Paul Bonanos STP938 Step Pharma S.A.S. CTP...
BioCentury | Sep 6, 2019
Company News

Management tracks: Prometheus, Step, Spero, NorthSea, Aristea, MODAG and more

...raise a series C next quarter followed by an IPO next year. Autoimmune disease company Step Pharma...
...Staff AbCellera Biologics Inc. Aristea Therapeutics Inc. Cabaletta Bio Inc. Fulcrum Therapeutics Inc. Locate Bio Ltd. Modag GmbH NorthSea Therapeutics B.V. Spero Therapeutics Inc. Step Pharma S.A.S. Precision...
BioCentury | Dec 14, 2018
Finance

Spreading good Kurma

...the new fund is built to do the same. Also launched under Biofund II were Step Pharma S.A.S....
BioCentury | Dec 14, 2018
Financial News

Kurma announces first close of €150 million Biofund III

...at the preseed stage to build start-ups. Through its second fund, Kurma co-created autoimmune company Step Pharma S.A.S....
BioCentury | Jul 6, 2018
Finance

Dynacure’s quick transfer

...S.A.S. raised €20 million ($21.8 million) in an April 2017 series A round. Autoimmune play Step Pharma S.A.S....
BioCentury | Dec 1, 2017
Financial News

Step Pharma adds €8.6M to series A

...Autoimmune play Step Pharma S.A.S. (Paris, France) raised €8.6 million ($10.2 million) in the second and final close...
...to treat autoimmune diseases from the Imagine Institute and its partners. Step Pharma S.A.S., Paris, France Elizabeth S. Eaton Step Pharma S.A.S. CTP...
BioCentury | Nov 21, 2017
Financial News

Step Pharma adds €8.6M to series A

...Autoimmune play Step Pharma S.A.S. (Paris, France) raised €8.6 million ($10.2 million) in the second and final close...
...of CTPS1 inhibitors to treat autoimmune diseases from the Imagine Institute and its partners. Elizabeth S. Eaton Step Pharma S.A.S. CTP...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...ImCheck Therapeutics S.A.S. 2015 Marseille, France Institut Paoli-Calmettes €20M ($21.8M) Next-generation immunomodulating antibodies Cancer Preclinical Step Pharma S.A.S....
...nucleotide synthesis inhibitors targeting CTP synthase 1 (CTPS1) Autoimmune; Cancer Preclinical Inserm Transfert Initiative (2012) Step Pharma S.A.S....
BioCentury | Feb 16, 2017
Emerging Company Profile

Autoimmunity alternative

...risks of broad immunosuppression, but the marketed compounds have serious side effects of their own. Step Pharma...
...CTPS1 inhibitors to treat autoimmune diseases from the Imagine Institute and its partners. COMPANY PROFILE Step Pharma S.A.S....
...Mentioned Hôpital Necker-Enfants Malades, Paris, France Imagine Institute, Paris, France Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Step Pharma S.A.S....
BioCentury | Jan 19, 2017
Finance

Kurma chameleon

...million but will manage over €100 million with co-investments from LPs, has formed four newcos: Step Pharma...
...managing partner Rémi Droller. According to Malier, the risk-sharing model came together after Kurma co-created Step Pharma...
...third highest for translational science among European countries between 2008 and 2016. Step by step Step Pharma...
Items per page:
1 - 10 of 10
BioCentury | Mar 24, 2021
Finance

With cancer foot forward, Step making strides toward clinic with €35M series B

...biotech concluded that the oncology route offered a shorter route to a potential accelerated approval.Now, Step Pharma S.A.S....
...Kurma were prior investors Pontifax and Bpifrance.TARGETSCTPS1 - CTP synthase 1CTPS2 - CTP synthase 2 Paul Bonanos STP938 Step Pharma S.A.S. CTP...
BioCentury | Sep 6, 2019
Company News

Management tracks: Prometheus, Step, Spero, NorthSea, Aristea, MODAG and more

...raise a series C next quarter followed by an IPO next year. Autoimmune disease company Step Pharma...
...Staff AbCellera Biologics Inc. Aristea Therapeutics Inc. Cabaletta Bio Inc. Fulcrum Therapeutics Inc. Locate Bio Ltd. Modag GmbH NorthSea Therapeutics B.V. Spero Therapeutics Inc. Step Pharma S.A.S. Precision...
BioCentury | Dec 14, 2018
Finance

Spreading good Kurma

...the new fund is built to do the same. Also launched under Biofund II were Step Pharma S.A.S....
BioCentury | Dec 14, 2018
Financial News

Kurma announces first close of €150 million Biofund III

...at the preseed stage to build start-ups. Through its second fund, Kurma co-created autoimmune company Step Pharma S.A.S....
BioCentury | Jul 6, 2018
Finance

Dynacure’s quick transfer

...S.A.S. raised €20 million ($21.8 million) in an April 2017 series A round. Autoimmune play Step Pharma S.A.S....
BioCentury | Dec 1, 2017
Financial News

Step Pharma adds €8.6M to series A

...Autoimmune play Step Pharma S.A.S. (Paris, France) raised €8.6 million ($10.2 million) in the second and final close...
...to treat autoimmune diseases from the Imagine Institute and its partners. Step Pharma S.A.S., Paris, France Elizabeth S. Eaton Step Pharma S.A.S. CTP...
BioCentury | Nov 21, 2017
Financial News

Step Pharma adds €8.6M to series A

...Autoimmune play Step Pharma S.A.S. (Paris, France) raised €8.6 million ($10.2 million) in the second and final close...
...of CTPS1 inhibitors to treat autoimmune diseases from the Imagine Institute and its partners. Elizabeth S. Eaton Step Pharma S.A.S. CTP...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...ImCheck Therapeutics S.A.S. 2015 Marseille, France Institut Paoli-Calmettes €20M ($21.8M) Next-generation immunomodulating antibodies Cancer Preclinical Step Pharma S.A.S....
...nucleotide synthesis inhibitors targeting CTP synthase 1 (CTPS1) Autoimmune; Cancer Preclinical Inserm Transfert Initiative (2012) Step Pharma S.A.S....
BioCentury | Feb 16, 2017
Emerging Company Profile

Autoimmunity alternative

...risks of broad immunosuppression, but the marketed compounds have serious side effects of their own. Step Pharma...
...CTPS1 inhibitors to treat autoimmune diseases from the Imagine Institute and its partners. COMPANY PROFILE Step Pharma S.A.S....
...Mentioned Hôpital Necker-Enfants Malades, Paris, France Imagine Institute, Paris, France Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Step Pharma S.A.S....
BioCentury | Jan 19, 2017
Finance

Kurma chameleon

...million but will manage over €100 million with co-investments from LPs, has formed four newcos: Step Pharma...
...managing partner Rémi Droller. According to Malier, the risk-sharing model came together after Kurma co-created Step Pharma...
...third highest for translational science among European countries between 2008 and 2016. Step by step Step Pharma...
Items per page:
1 - 10 of 10